Bioventus Inc. (BVS)
NASDAQ·Healthcare·Medical - Devices
$9.90
-1.15%
Mkt Cap $679.74M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $154.95M | $157.90M | +1.91% | $0.22 | $0.24 | +9.09% | — | — |
| Q4 2025 Nov 4, 2025 | $155.70M | $138.65M | -10.95% | $0.21 | $0.15 | -30.23% | — | — |
| Q3 2025 Aug 6, 2025 | $138.78M | $147.66M | +6.40% | $0.22 | $0.21 | -4.55% | — | — |
| Q2 2025 May 6, 2025 | $145.85M | $123.88M | -15.07% | $0.06 | $0.08 | +33.33% | — | — |
| Q1 2025 Mar 11, 2025 | $124.50M | $153.64M | +23.41% | $0.08 | $0.15 | +87.50% | — | — |
| Q4 2024 Nov 5, 2024 | $144.83M | $138.96M | -4.05% | $0.06 | $0.06 | +0.00% | — | — |
| Q3 2024 Aug 6, 2024 | $137.59M | $151.22M | +9.90% | $0.07 | $0.19 | +171.43% | — | — |
| Q2 2024 May 7, 2024 | $118.38M | $129.46M | +9.36% | -$0.05 | $0.07 | +240.00% | — | — |
| Q1 2024 Mar 12, 2024 | $123.96M | $135.42M | +9.25% | $0.06 | $0.07 | +16.67% | — | — |
| Q4 2023 Nov 7, 2023 | $123.96M | $120.79M | -2.55% | $0.06 | $0.05 | -16.67% | — | — |
| Q3 2023 Aug 8, 2023 | $129.23M | $137.07M | +6.07% | $0.03 | $0.14 | +366.67% | — | — |
| Q2 2023 May 16, 2023 | $116.58M | $119.06M | +2.13% | -$0.11 | -$0.26 | -136.36% | — | — |
| Q1 2023 Mar 31, 2023 | $132.70M | $125.83M | -5.17% | $0.05 | -$0.06 | -220.00% | — | — |
| Q4 2022 Nov 21, 2022 | $141.59M | $128.66M | -9.13% | $0.13 | $0.05 | -61.54% | — | — |
| Q3 2022 Aug 11, 2022 | $138.33M | $140.33M | +1.44% | $0.14 | $0.10 | -28.57% | — | — |
| Q2 2022 May 10, 2022 | $117.69M | $117.29M | -0.34% | $0.05 | $0.04 | -16.67% | — | — |
| Q1 2022 Mar 10, 2022 | $130.23M | $130.41M | +0.14% | $0.20 | $0.26 | +30.00% | — | — |
| Q4 2021 Nov 9, 2021 | $104.95M | $108.89M | +3.75% | $0.13 | $0.25 | +92.31% | — | — |
| Q3 2021 Aug 10, 2021 | $109.82M | $109.82M | +0.00% | $0.10 | $0.16 | +60.00% | — | — |
| Q2 2021 May 12, 2021 | $478.40M | $81.78M | -82.91% | -$0.01 | -$0.02 | -57.85% | — | — |